When evaluating groundnuts (peanuts) versus cashews for cardiovascular health, groundnuts generally have a slight clinical edge in both their fatty acid profile and the volume of evidence supporting their cardioprotective effects, though both offer distinct metabolic benefits.
Fatty Acid Profile and Lipid Metabolism
- Groundnuts: As legumes, groundnuts possess a highly favorable ratio of monounsaturated (oleic acid) and polyunsaturated (linoleic acid) fats. Clinical trials, such as the ARISTOTLE study (different from the Apixaban versus Warfarin ARISTOTLE Trial), demonstrate that regular peanut consumption significantly lowers triglycerides and improves both TC/HDL and LDL/HDL ratios.
- Cashews: Cashews contain less total fat than groundnuts but have a relatively higher proportion of saturated fat. However, the primary saturated fatty acid in cashews is stearic acid, which has a well-documented neutral effect on circulating LDL cholesterol compared to palmitic or myristic acids. While some trials show cashew consumption slightly lowers LDL, meta-analyses frequently indicate their overall impact on the lipid profile is neutral, though they do effectively lower triglycerides. It is also worth noting that cashews have a higher carbohydrate and lower protein content compared to peanuts.
Vascular and Endothelial Function
- Groundnuts: They are an excellent source of L-arginine. As the primary precursor for endothelial nitric oxide synthesis, this amino acid plays a direct role in maintaining vascular tone and improving flow-mediated dilation. Peanuts also contain resveratrol and higher levels of Vitamin E, offering substantial antioxidant protection against LDL oxidation.
- Cashews: Where cashews excel is in their micronutrient density, particularly magnesium and potassium. This gives them a notable advantage in blood pressure regulation. Meta-analyses have consistently shown that targeted cashew interventions lead to statistically significant reductions in both systolic and diastolic blood pressure.
Epidemiological Evidence
Both options demonstrate a strong inverse relationship with coronary heart disease in major prospective cohorts. However, the overall evidence base for peanuts is more robust, largely due to their broader global consumption and inclusion in more extensive, long-term dietary studies.
Summary
For primary lipid optimization—specifically triglyceride reduction and improving lipoprotein ratios—or for endothelial support, groundnuts are the superior choice. If the clinical focus is more heavily weighted toward managing mild hypertension, the high magnesium content in cashews makes them a highly effective alternative.
Here are the primary research links and study details supporting the cardiovascular impacts of cashews and groundnuts (peanuts):
Cashews and Blood Pressure
- Study: Cashew Nut Consumption Increases HDL Cholesterol and Reduces Systolic Blood Pressure in Asian Indians with Type 2 Diabetes: A 12-Week Randomized Controlled Trial.
- Overview: This randomized controlled trial demonstrated that incorporating cashews into a prescribed diet significantly reduced systolic blood pressure and increased HDL cholesterol without deleterious effects on body weight or glycemia.
- Link: https://pubmed.ncbi.nlm.nih.gov/29378038/
Groundnuts, General Nuts, and Lipid/Cardiovascular Profiles
- Study: Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies.
- Overview: A highly comprehensive meta-analysis calculating that an increase in nut intake (including peanuts) is robustly associated with a reduced risk of coronary heart disease, stroke, and overall cardiovascular disease.
- Link: https://pubmed.ncbi.nlm.nih.gov/27916000/
Epidemiological Evidence (Foundational Research)
- Study: A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study.
- Overview: This is a foundational prospective cohort study establishing the inverse relationship between frequent nut consumption (more than four times per week) and a substantially lower risk of definite fatal and nonfatal coronary heart disease events.
- Link: https://pubmed.ncbi.nlm.nih.gov/1627021/
Endothelial Function and Bioactive Compounds
- Study: Resveratrol and Vascular Function & Resveratrol and Endothelial Nitric Oxide.
- Overview: These papers detail the mechanisms by which resveratrol—a polyphenol heavily present in peanuts—increases nitric oxide production via endothelial nitric oxide synthase (eNOS). This action relaxes blood vessels, reduces blood pressure, and provides critical endothelial support.
- Links: https://pmc.ncbi.nlm.nih.gov/articles/PMC6539341/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC6270738/